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The Protein Data Bank (PDB) is the largest available repository of solved
protein structures and contains a wealth of information on successful
crystallization. Many centres have used their own experimental data to draw
conclusions about proteins and the conditions in which they crystallize. Here,
data from the PDB were used to reanalyse some of these results. The most
successful crystallization reagents were identiﬁed, the link between solution pH
and the isoelectric point of the protein was investigated and the possibility of
predicting whether a protein will crystallize was explored.
1. Introduction
The Protein Data Bank (PDB) is an open-access online
repository containing information about solved protein
structures (Berman et al., 2000). Along with the atomic co-
ordinates, associated metadata may include the sequence of
the protein, its species of origin and details of expression and
structure determination. From seven structures in 1971, the
number of structures in the databank has grown to over
109 000 (Protein Data Bank, 2015). The predominant method
of structure determination, accounting for 89% of the entries,
is X-ray crystallography. However, only 18% of puriﬁed
proteins produce diffraction-quality crystals, with the highest
attrition rate being at the crystallization stage (TargetTrack,
2015).
Various methods have been developed to predict whether
a protein will crystallize based only on features derived from
protein sequences (Jahandideh & Mahdavi, 2012). Features
include numerical variables representing various biophysical
properties, such as the isoelectric point (pI) and the grand
average of hydropathy (GRAVY; Kyte & Doolittle, 1982), as
well as the frequencies of dipeptide and tripeptide amino-acid
compositions. Different feature sets have been calculated and
used to train machine-learning algorithms, including neural
networks (Kurgan et al., 2009; Overton et al., 2011). Here,
we use a feed-forward neural network to classify protein
sequences as either crystallizable or noncrystallizable and
apply the trained classiﬁer to data in the PDB.
Researchers have attempted to improve crystallization
success rates by using statistical analysis of crystallization data
repositories. The success rates of various crystallization
reagents have been estimated (Rupp & Wang, 2004) and
minimal sets of conditions that could crystallize most proteins
in a given data set have been obtained (Kimber et al., 2003;
Page et al., 2003). Scientists from structural genomics centres
recently documented their support for mining data to improve
crystallization, but commented that the range of proteins
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should be diverse (Newman, Bolton et al., 2012; Gorrec, 2014).
Although the PDB contains a wide variety of protein struc-
tures, the corresponding information on crystallization has
been difﬁcult to access on a large scale. Crystallization details
are captured as free-text input held in the ‘REMARK 280’
lines of a PDB ﬁle and require standardiziation in order to
extract useful information. For example, ammonium sulfate
has been recorded as at least 30 different abbreviations and
text variants (Peat et al., 2005). We use a standardized snap-
shot of the PDB with crystallization conditions for 63 002
PDB entries that overcomes problems with inconsistencies in
nomenclature (Fazio et al., 2014; Newman et al., 2014) to revisit
some previously reported analyses. We investigate the rela-
tionship between the pI of a protein and the pH at which it
crystallizes, using an estimate for the pH that takes into
account the effect of other chemicals on the buffer pH, and
identify the most prevalent chemicals in the PDB.
2. Methods and materials
Each PDB ID in the standardized PDB (obtained from Fazio
et al., 2014) is associated with a protein sequence and the
components of the crystallization solution. The data are not
completely clean; for example, one entry has a reported
concentration of 200 000 mMmagnesium formate and in other
entries a chemical appears more than once in the parsed data.
After removing entries with concentrations higher than the
maximum solubility levels and those with repeated chemicals,
the number of PDB IDs was reduced to 60 999 to form the
data set that we refer to as PDB-RAW.
Some proteins have been deposited in the PDB many times
with different ligands, modiﬁcations or crystallization space
groups. For example, hen egg-white lysozyme (Gallus gallus
lysozyme) is associated with 460 X-ray structures. While
redundancy is useful for some types of analysis, in other cases
it skews the results. We therefore considered the data at
different levels of redundancy.
DNA sequences and duplicate identical protein sequences
were removed from PDB-RAW to give the subset PDB-
UNIQUE comprising 37 249 PDB entries. The PDB-RAW
protein sequences were also analysed using BLAST (Madden,
2012) with a p-value of 107 to determine whether sequences
should be considered to be the same. The PDB-BLAST subset
consists of protein entries grouped according to the BLAST
analysis, with 8958 groups each containing between one and
2115 IDs, giving 59 734 entries in total. The PDB-BLAST data
set was reduced to 44 063 PDB entries by removing duplicate
entries with the same experimental conditions for the same
protein (but keeping all entries for the same protein where the
experimental conditions differ), referred to as PDB-BLAST-
reduced (Fig. 1).
2.1. Estimation of pH
One of the most important parameters in crystallization is
the pH of the experiment (McPherson, 1989; Newman, Sayle
et al., 2012). It is usually the pH of the buffer component that is
recorded rather than the pH of the ﬁnal crystallization solu-
tion, which can differ by up to three pH units (Bukrinsky &
Poulsen, 2001; Wooh et al., 2003). Kirkwood et al. (2015)
describe the use of a neural network to provide a more
accurate estimate of the pH of the crystallization solution. The
network was trained to predict the effect of different chemical
groups [salts, salts of weak acids, organics, polyethylene glycols
(PEGs), compounds containing ammonia, hydroxide and
dihydrogen salts] on the buffer pH, which can then be adjusted
according to the concentrations of the other chemicals in the
solution. The network cannot predict the effect of chemicals
that do not belong to a group used in training and requires
the buffer pH to be known. Therefore, a further 1601 entries
involving chemicals for which the effect on pH is unknown
or with no recorded buffer pH were removed from PDB-
research communications
Acta Cryst. (2015). F71, 1228–1234 Kirkwood et al.  Analysis of crystallization data in the PDB 1229
Figure 1
The structure of the data used for different types of analysis, showing the number of PDB entries in the various data subsets.
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UNIQUE to form the subset PDB-pH, as shown in Fig. 1, and
the network was used to provide the pH for this subset.
2.2. Prediction of crystallizability
Overton et al. (2008) formed the FEAT data set using
1456 sequences obtained from TargetDB (now TargetTrack;
TargetTrack, 2015; Chen et al., 2004). This data set comprises
50% annotated as ‘work stopped’ (noncrystallizable) and 50%
annotated as ‘diffraction quality crystal’ (crystallizable). The
TEST-NEW data set, consisting of a further 1000 sequences
of each class (also obtained from TargetDB), was used as an
independent test set. We perform a similar analysis using the
same training and test data sets, but using a feed-forward
neural network with the features pI, GRAVY and counts of
the amino acids Asp, Cys, Gly, His, Met, Phe, Pro, Ser, Thr, Trp
and Tyr used previously in an approach using Parzen window
density estimation (Overton et al., 2008). We used the
Levenberg–Marquardt method in Matlab (MathWorks) to
train the network with two hidden layers, each having two
nodes with sigmoid-tangent transfer functions. The trained
model was then used to predict sequences found in the PDB.
3. Results and discussion
Fig. 2 shows the numbers of structures in the PDB-RAW and
PDB-UNIQUE data sets plotted in ﬁve-year periods. One
explanation for the decrease in the proportion of signiﬁcantly
different structures is the focus on drug discovery, with a
limited number of target proteins and the need for protein–
ligand complexes.
3.1. Analysis of chemical usage in the PDB
The interactions between a protein and the various
chemicals used in crystallization are complex and the number
of possible combinations grows exponentially as the number
of chemicals at different concentrations is increased (Rupp &
Wang, 2004). Rather than explore chemical space randomly,
most crystallization screens are designed rationally, making
use of prior knowledge (Jancarik & Kim, 1991). It is therefore
of interest to consider the most widely used conditions in the
PDB and whether these have changed in recent years.
Table 1 shows the ten most prevalent chemicals in the PDB-
BLAST-reduced data set, which includes some proteins more
than once, provided that the experimental conditions used to
generate the crystals differed. Polyethylene glycol 3350 (PEG
3350) is the most widely used chemical, followed closely by
Tris buffer and ammonium sulfate. Considering all molecular-
weight PEGs together (including monomethyl ethers) shows
that this group of chemicals occurs in 15 910/44 063 (36%) of
all conditions analysed. PEG (6000) was, to the best of our
knowledge, ﬁrst used to crystallize ‘alcohol oxidase’ in 1968
(Janssen & Ruelius, 1968). However, it was not until ten years
later that McPherson (1976) studied the use of PEGs for
crystallizing proteins and found that a screen containing PEGs
of various weights and concentrations produced crystals for 13
of the 22 proteins tested, six of which had not been crystallized
before. McPherson concluded that it may be the best initial
trial reagent for crystallization.
Subsequent studies have provided further evidence to
support the use of PEGs (Hui & Edwards, 2003; McPherson,
1999). In 1984, PEG was identiﬁed as the second most widely
used chemical in crystallization (Gilliland & Davies, 1984) and
in 1991 PEGs were included in half (25/50) of the conditions of
Jancarik and Kim’s popular sparse-matrix screen (Jancarik &
Kim, 1991). PEGs are amongst the most prevalent chemicals
in the PDB (Peat et al., 2005), with PEG 3350 recently over-
taking ammonium sulfate as the single most abundant
chemical (Fig. 3).
The prevalence of PEGs has also been shown for a set of
nonredundant proteins (Fazio et al., 2014). The C6 metric, a
similarity measure for crystallization conditions, considers
PEGs with molecular weights that differ by less than a factor
of two to be the same (Newman et al., 2010). Together, PEG
4000 and PEG 3350 can be considered to be the most
successful reagent in the history of the PDB. Although the
mechanism that makes PEGs such efﬁcacious crystallization
reagents is not well understood, it seems that they may force
the protein out of solution by competing with water molecules
for interactions (McPherson, 1989; Lee & Lee, 1981). The
research communications
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Figure 2
The number of structures deposited in the PDB in ﬁve-year periods since
1995. The number of structures deposited is shown together with the
number of structures within each of the groups PDB-RAW and PDB-
UNIQUE.
Table 1
The ten most prevalent chemical species with the number of entries in the
PDB-BLAST-reduced data set consisting of 44 063 PDB entries.
Rank Chemical Count
1 Polyethylene glycol 3350 9264
2 Tris 8375
3 Ammonium sulfate 8225
4 HEPES 5795
5 Polyethylene glycol 4000 5637
6 Sodium chloride 5248
7 Sodium acetate 5194
8 Polyethylene glycol 8000 4095
9 Magnesium chloride 3845
10 MES 3664
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varying weights and lengths enable a steric exclusion
mechanism that excludes protein from areas of the solution,
thereby increasing local activity and solubility (Laurent, 1963;
Ward et al., 1975). At neutral pH they do not require large
concentrations of buffer (Kirkwood et al., 2015), but they are
known to degrade over time, making experiments difﬁcult to
reproduce (Ray & Puvathingal, 1985)
The other most prevalent chemicals are either buffers
(HEPES, Tris and MES), which are used to control pH and are
assumed to be otherwise chemically inert with respect to
crystallization (although this is contestable; McPherson, 1995),
or the salts ammonium sulfate, sodium and magnesium
chloride and sodium acetate (also a buffer). Differential
scanning ﬂuorimetry has shown that proteins are stabilized by
moderate concentrations of salt in their buffer formulations
(Ristic et al., 2015). Increased salt concentration may either
stabilize the protein solution further (potentially allowing the
protein concentration to be increased) or decrease the protein
solubility causing precipitation: the so-called ‘salting-in’ and
‘salting-out’. It is assumed that the concentration of salt affects
the hydration shell around the protein, which in some
instances may facilitate the protein–protein interactions
necessary to drive nucleation and crystallization. Zhang &
Cremer (2006) showed that different ions, categorized in the
Hofmeister series, vary with respect to this effect. Magnesium
ions at high concentrations are able to precipitate proteins in a
similar fashion to sulfate ions, although they are generally less
successful in crystallization. The biological role of magnesium
and calcium, both catalytically and structurally, may be
reﬂected in the success of these salts at low concentrations in
crystallization trials, with these ions often appearing in crystal
structures (Kretsinger, 1976; Jayachandran et al., 2007).
The salts in Table 1 have been identiﬁed previously in
successful crystallization conditions using data from the PDB
(Peat et al., 2005) and the BMCD (Lu et al., 2012). In a
comparison of the success rates for 12 different salts, ammo-
nium sulfate was identiﬁed as one of the most successful salts,
although sodium malonate was found to be more than twice
as successful (McPherson, 2001). Rupp & Wang (2004) also
found that the success rate for ammonium sulfate was higher
than the average rate for their data, whereas that for
magnesium chloride was worse than average. Although these
salts occur frequently in successful crystallization conditions,
they are often found in combination with PEGs, making the
contribution of individual components difﬁcult to assess.
In fact, 83% of solutions containing magnesium chloride also
contained PEGs. Similarly, 61% of solutions containing
sodium chloride and 39% of solutions containing ammonium
sulfate also contained PEGs.
We found that some additives appear in very few successful
crystallization solutions, with 268 chemicals used less than
ﬁve times and 108 leading to a single protein structure (see
Supplementary Table S1). For 83 of these 108 chemicals (76%)
a protein structure was obtained for the same BLAST group
using alternative conditions. The 25 chemicals that did lead to
a unique protein structure, eight of which are ligands, might be
considered a last-resort list.
3.2. Analysis of pH and the relationship to pI
It is well documented that estimating the pH of a crystal-
lization solution as that of the buffer component can be
inaccurate (Kirkwood et al., 2014; Newman, Sayle et al., 2012;
Bukrinsky & Poulsen, 2001). Chemical species such as PEGs
and ammonium-containing compounds are known to degrade
over time, thereby modifying the pH (Newman, Sayle et al.,
2012; Jurnak, 1986; Mikol et al., 1989; Hampton Research,
2012). Crystallization solutions can be cooled to prevent
degradation, although temperature also affects solubility
(Beynon & Easterby, 1996).
By using the method of Kirkwood et al. (2015) to predict the
effect of nonbuffer components for crystallization solutions in
the PDB-pH data set, we were able to determine an accurate
distribution of pH in the PDB. For the 35 648 conditions that
could be predicted, we found this to be normal with a mean
close to pH 7 (Fig. 4). A normal distribution was also reported
by Samudzi et al. (1992) in their analysis of the BMCD, but
with a slightly lower mean of pH 6.5. Similar results were
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Figure 4
The distribution of adjusted pH values from PDB-pH obtained using a
model to predict the effect on the buffer pH of other components of the
crystallization solution. Values show the centre of the half-pH unit bins.
Figure 3
The occurrence of PEG 3350 and PEG 4000 in comparison to ammonium
sulfate as found in PDB-BLAST-reduced, showing that the latter has
recently been overtaken by PEG 3350 as the most prevalent chemical in
crystallization trials. Normalization was performed by dividing the count
of each chemical by the number of PDB entries for each ﬁve-year
interval.
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reported by Rupp & Wang (2004), but Kantardjieff & Rupp
(2004) and Bonnete´ (2007) showed a bimodal distribution for
the buffer pH with modes close to pH 6 and 9. It is interesting
to note that Rupp reported two different distributions of
buffer pH for crystallization solutions in the same year. A
possible explanation is the source of the data, with one data
set obtained from a structural genomics centre and the other
from the more varied BMCD.
The isoelectric point of a protein is deﬁned as the pH at
which the net charge on the protein is zero. This is a calculated
parameter based on the assumption that charged residues are
not buried in the hydrophobic core of the molecule and are
therefore solvent-accessible. In order to concentrate a protein
solution for crystallization experiments it is generally accepted
that a buffer pH should be chosen taking the protein pI into
consideration to avoid solubility issues (Luft et al., 2011;
Zhang et al., 2013). It is possible to calculate the pI based on
the primary sequences recorded in the PDB and to look for
correlation with the experimental pH. This has been
performed before and no signiﬁcant correlation has been
found (Page et al., 2003; Huber & Kobe, 2004; Wooh et al.,
2003), but here we use pH values adjusted to account for the
chemicals in the crystallization solution in addition to the
buffer. Isoelectric points were determined for the 23 949
entries in PDB-UNIQUE for which the full sequence is known
and an accurate pH can be determined (PDB-pH-pI).
Previous studies suggested the pI to be bimodally distributed
(Canaves et al., 2004; Kantardjieff & Rupp, 2004), whereas we
observe a trimodal distribution for the PDB data with peaks
close to pH 4.8, 6.6 and 9.0 (Fig. 5). The relationship between
the pI of proteins and the pH at which they have been crys-
tallized is shown in Fig. 6. Acidic proteins, i.e. those with a pI
below 7, tend to crystallize about one pH unit above their pI,
whereas basic proteins tend to crystallize below their pI by
around 1.5–3 pH units. These results support previous ﬁndings
(Kantardjieff et al., 2004; Kantardjieff & Rupp, 2004; Charles
et al., 2006).
3.3. Analysis of protein properties
Fig. 6 shows that the majority of crystallized proteins are
acidic. In general, proteins that are both acidic and hydrophilic
are considered to be more likely to crystallize (Canaves et al.,
2004), whilst those that are both basic and hydrophobic are
less likely. As both the acidity and the hydrophobicity can be
calculated from a protein sequence, a prediction can be made
as to whether a protein will crystallize (Smialowski et al., 2006;
Overton & Barton, 2006; Slabinski et al., 2007; Overton et al.,
2008, 2011; Mizianty & Kurgan, 2009; Kurgan et al., 2009;
Babnigg & Joachimiak, 2010; Kandaswamy et al., 2010). The
confusion matrix in Fig. 7 shows that 73.9% of the sequences
in the TEST-NEW data set were predicted correctly by our
neural network, with slightly more true positives (790) than
true negatives (687). However, this model does not generalize
to the PDB data, with only 55% of sequences correctly
predicted as crystallizable. Restricting the PDB data to
sequences submitted between July 2006 and December 2008
to reﬂect the TEST-NEW data set did little to improve the
accuracy, with just 58% (3180/5453) correctly predicted. As
shorter sequences are not well represented in the FEAT data
set, we also tried restricting the PDB data to sequences with
more than 99 amino acids, resulting in an accuracy of just 58%
(13 233/22 829). To be sure that the low prediction rates were
not particular to our network, we used the online predictor
CRYSTALP2 (Kurgan et al., 2009) with a random sample of
1000 sequences from the PDB with between 100 and 1000
residues. Again the accuracy was low, with just 60% of the
sequences classiﬁed as ‘crystallizable’.
In the original training and test data sets, crystallizable
proteins were obtained from TargetDB (TargetTrack) if
annotated as having ‘diffraction quality crystals’, but speciﬁ-
cally not ‘in PDB’ in the ‘status’ ﬁeld (Kurgan et al., 2009). The
motivation for excluding sequences resulting in PDB struc-
tures is not given. It seems there are sequence differences
between proteins designated as producing diffraction-quality
crystals in TargetDB and those that result in a structure
deposited in the PDB. One possible explanation is the fact that
only structural genomics targets are included in TargetDB and
may be restricted, for example owing to particular medical
research communications
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Figure 6
The distribution of the difference between the pH at which a structure
was obtained and the isoelectric point of 23 949 proteins in the PDB-pH-
pI data set. The distributions are shown separately for proteins with a pI
lower than 7 (acidic) and those with a pI greater than 7 (basic). Those
with a pH of precisely 7 (of which there were four) were grouped with the
basic proteins.
Figure 5
The distribution of calculated pI for 23 949 signiﬁcantly different proteins
in the PDB-pH-pI data set.
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interests, whereas structures deposited in the PDB are from
a wider, and potentially more difﬁcult to crystallize, range of
proteins. We cannot assume that diffraction data were actually
collected for proteins annotated as producing diffraction-
quality crystals; in fact, diffraction data are collected for about
a third of the structural genomics targets for which crystals are
obtained, and only two-thirds of these result in a protein
structure in the PDB (Westbrook et al., 2003).
4. Conclusions
Statistical analysis of the data from successful experiments
can provide useful information for the development of new
crystallization strategies. Our analysis of the PDB broadly
conﬁrms previous ﬁndings, with the distribution of pH values
as expected, and justiﬁes the use of PEG as the ‘go to’ reagent
of choice and shows magnesium chloride to be a successful
crystallization agent, albeit predominantly in solution with
PEG. The lack of correlation between the pH of crystallization
and pI was conﬁrmed and the patterns observed, with acidic
proteins tending to crystallize at a pH just above their pI and
basic proteins tending to crystallize below their pI, can be
attributed to the fact that, on average, proteins crystallize
at neutral pH. Sequence-based algorithms to predict the
propensity of a protein to crystallize (Smialowski et al., 2006;
Jahandideh & Mahdavi, 2012) have been optimized using
targets from particular protein families and do not appear to
generalize to proteins with structures deposited in the PDB.
In order to retrain classiﬁcation algorithms, suitably
unbiased data on unsuccessful crystallization trials would also
be needed. Such data are also necessary to investigate the
relationship between protein properties and the conditions
that result in crystals (Hennessy et al., 2000). This could
potentially allow properties that can be measured or calcu-
lated before crystallization trials begin to be used to predict
the best initial conditions to try.
The standardized PDB facilitates data-mining studies and
could be used to investigate other indicators of the ability of a
protein to crystallize including, for example, molecular weight
and domain structure. Is low molecular weight better than
high molecular weight, are single-domain proteins more likely
to crystallize than multi-domain proteins and is an oligomeric
state multimer better than a monomer? However, consistency
in the reporting of metadata is crucial to such studies and the
use of IUPAC names for all chemical entries in the PDB (not
just ligands) would certainly help.
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